Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Revenue

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,669 Cr₹1,541 Cr₹1,242 Cr₹1,107 Cr₹968 Cr

What is the latest Revenue of INDOCO REMEDIES ?

The latest Revenue ratio of INDOCO REMEDIES is ₹1,669 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,669 Cr
Mar2023₹1,541 Cr
Mar2022₹1,242 Cr
Mar2021₹1,107 Cr
Mar2020₹968 Cr

How is Revenue of INDOCO REMEDIES Trending?

Years Revenue % Change
Mar2024 ₹1,669 Cr
8.30
Mar2023 ₹1,541 Cr
24.10
Mar2022 ₹1,242 Cr
12.19
Mar2021 ₹1,107 Cr
14.26
Mar2020 ₹968 Cr -

Compare Revenue of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,920.0 Cr 0.1% 7.5% 0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.1%

7.5%

0.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses